ng-nitroarginine methyl ester and Abnormalities, Cardiovascular

ng-nitroarginine methyl ester has been researched along with Abnormalities, Cardiovascular in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Khamseekaew, J; Maneesai, P; Pakdeechote, P; Poasakate, A; Potue, P; Rattanakanokchai, S; Sangartit, W	1

Other Studies

1 other study(ies) available for ng-nitroarginine methyl ester and Abnormalities, Cardiovascular

Article	Year
Kaempferol protects against cardiovascular abnormalities induced by nitric oxide deficiency in rats by suppressing the TNF-α pathway. European journal of pharmacology, 2023, Dec-05, Volume: 960 Topics: Animals; Antioxidants; Aorta; Blood Pressure; Cardiovascular Abnormalities; Hypertension; Hypertrophy; Kaempferols; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phosphatidylinositol 3-Kinases; Rats; Tumor Necrosis Factor-alpha	2023

Article

Year

Kaempferol protects against cardiovascular abnormalities induced by nitric oxide deficiency in rats by suppressing the TNF-α pathway.

European journal of pharmacology, 2023, Dec-05, Volume: 960

Topics: Animals; Antioxidants; Aorta; Blood Pressure; Cardiovascular Abnormalities; Hypertension; Hypertrophy; Kaempferols; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phosphatidylinositol 3-Kinases; Rats; Tumor Necrosis Factor-alpha

2023